Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Intelligent Bio Solutions ( (INBS) ) has provided an announcement.
On July 16, 2025, Intelligent Bio Solutions Inc. announced a global distribution agreement with Smartox LLC to introduce its SmarTest Patch drug detection product to international markets outside the U.S. and Canada. This partnership strengthens the company’s position in non-invasive drug testing solutions and aligns with its international growth strategy, opening new opportunities in the justice and rehabilitation sectors. The global drug testing market is projected to grow significantly, and this agreement provides an additional revenue stream for Intelligent Bio Solutions. The company is also focused on securing FDA clearance for its fingerprint sweat-based drug testing technology to expand its U.S. market presence.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Neutral.
INBS’s overall stock score reflects a mixed outlook, with positive technical momentum and promising corporate events being the most significant factors. However, financial performance and valuation are constrained by negative earnings and cash flow. While there are growth opportunities through expansion and innovation, the lack of profitability remains a primary concern.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. is a medical technology company specializing in intelligent, rapid, non-invasive testing solutions. The company is known for its Intelligent Fingerprinting Drug Screening System, which uses fingerprint sweat analysis to detect recent drug use. This system is designed to be hygienic and cost-effective, providing results in under ten minutes. The company’s market focus includes safety-critical industries such as construction, manufacturing, transport, and logistics, as well as drug treatment organizations and coroners.
Average Trading Volume: 144,044
Technical Sentiment Signal: Sell
Current Market Cap: $11.95M
For an in-depth examination of INBS stock, go to TipRanks’ Overview page.